The city of St Louis, Missouri, currently has 1 active clinical trials seeking participants for Pancreatic Cancer research studies.
Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach
Recruiting
This trial is a single-arm, prospective, multi-center clinical trial designed to demonstrate that stereotactic adaptive radiotherapy using an ablatively dosed (50Gy,5fx) for treatment of borderline-resectable, locally-advanced , or medically inoperable pancreatic adenocarcinoma will translate into a decreased toxicity. The study will evaluate GI toxicity, overall survival, local control, quality of life, and workflow metrics.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/17/2025
Locations: Washington University, St. Louis, St Louis, Missouri
Conditions: Pancreatic Cancer